Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbohydrate-based therapeutics.

Helen M I Osborn1, Philip G Evans, Natasha Gemmell

  • 1School of Chemistry, University of Reading, Whiteknights, Reading RG6 6AD, UK. h.m.i.osborn@rdg.ac.uk

The Journal of Pharmacy and Pharmacology
|July 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biodegradable cross-linked flavone networks featuring either ester or carbamate linkages for controlled delivery of anti-cancer agents.

RSC advances·2026
Same author

A framework for quantum-secure communications in cyber-physical control systems with experimental demonstration in nuclear a reactor.

Scientific reports·2026
Same author

Polymeric PEG-based bioorthogonal triggers for prodrug activation in breast cancer.

RSC advances·2025
Same author

Selective activation of prodrugs in breast cancer using metabolic glycoengineering and the tetrazine ligation bioorthogonal reaction.

Bioorganic chemistry·2024
Same author

Elevated concentrations of Neu5Ac and Neu5,9Ac<sub>2</sub> in human plasma: potential biomarkers of cardiovascular disease.

Glycoconjugate journal·2023
Same author

Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction.

RSC medicinal chemistry·2023
Same journal

Norisoboldine suppresses epithelial-mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway.

The Journal of pharmacy and pharmacology·2026
Same journal

Development, characterization, and therapeutic evaluation of uniform dezocine-loaded PLGA microspheres for sustained analgesia and cognitive protection.

The Journal of pharmacy and pharmacology·2026
Same journal

Phytochemical constituents, biological activities, toxicological profiles, and current applications of Muntingia calabura L.: an updated review.

The Journal of pharmacy and pharmacology·2026
Same journal

Uterine relaxant effects of Ageratum conyzoides essential oil: influence of hormonal status and calcium modulation.

The Journal of pharmacy and pharmacology·2026
Same journal

Liraglutide-mediated protection against ethanol-induced gastric ulcer in male and female rats: enhancement of mucosal defense, anti-inflammatory and antioxidant mechanism.

The Journal of pharmacy and pharmacology·2026
Same journal

Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways.

The Journal of pharmacy and pharmacology·2026
See all related articles

Carbohydrates play key roles in diseases. This review covers new carbohydrate-based therapies, including enzyme inhibitors and drug delivery systems, offering promising treatments for various conditions.

Area of Science:

  • Biochemistry
  • Glycoscience
  • Medicinal Chemistry

Background:

  • Growing recognition of carbohydrates' involvement in diverse disease processes.
  • Recent resurgence in interest in the biological functions of carbohydrates.

Purpose of the Study:

  • To review advancements in carbohydrate-based therapeutic strategies.
  • To highlight novel approaches targeting carbohydrate-related disease mechanisms.

Main Methods:

  • Summarizing progress in developing carbohydrate-based therapeutics.
  • Reviewing strategies such as inhibiting carbohydrate-lectin interactions.
  • Examining immunisation approaches using monoclonal antibodies for carbohydrate antigens.
  • Assessing enzyme inhibition and replacement therapies.

Related Experiment Videos

  • Evaluating drug targeting via carbohydrate-lectin interactions.
  • Considering carbohydrate-based anti-thrombotic agents.

    • Main Results:

    • Significant progress has been made in developing carbohydrate-based therapeutics.
    • Multiple therapeutic avenues are being explored, including direct inhibition and immunisation.
    • Novel drug delivery and anti-thrombotic strategies are emerging.

    Conclusions:

    • Carbohydrate-based therapeutics represent a promising frontier in medicine.
    • Targeting carbohydrate-related pathways offers diverse treatment options.
    • Continued research in glycoscience is crucial for developing effective therapies.